Harpoon Therapeutics Inc
(HARP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 8,303 | 5,906 | 4,325 | 4,484 | 5,838 |
| Gross Profit | 8,303 | 5,906 | 4,325 | 4,484 | 5,838 |
| Operating Expenses | 25,714 | 26,219 | 25,866 | 21,159 | 22,606 |
| Operating Income | -17,411 | -20,313 | -21,541 | -16,675 | -16,768 |
| Other Income | 60 | -8 | -10 | -7 | 4 |
| Pre-tax Income | -17,351 | -20,321 | -21,551 | -16,682 | -16,764 |
| Net Income Continuous | -17,351 | -20,321 | -21,551 | -16,682 | -16,764 |
| Net Income | $-17,351 | $-20,321 | $-21,551 | $-16,682 | $-16,764 |
| EPS Basic Total Ops | -5.30 | -6.20 | -6.40 | -5.10 | -5.20 |
| EPS Basic Continuous Ops | -5.25 | -6.18 | -6.35 | -5.11 | -5.16 |
| EPS Diluted Total Ops | -5.30 | -6.20 | -6.40 | -5.10 | -5.20 |
| EPS Diluted Continuous Ops | -5.25 | -6.18 | -6.35 | -5.11 | -5.16 |
| EPS Diluted Before Non-Recurring Items | -5.30 | -6.20 | -6.60 | N/A | N/A |
| EBITDA(a) | $-17,168 | $-19,404 | $-20,468 | $-15,455 | $-15,625 |